In the era of the rapid development of new diagnostic modalities and novel targeted treatment options, a comprehensive diagnostic approach to myelodysplastic and myeloproliferative neoplasms becomes ever more critical. However, the rapidly evolving scientific and technological discoveries that have been continuously incorporated into the classification of myelodysplastic and/or myeloproliferative neoplasms significantly increase already complex hematopathology practice. (Hemato)pathologists are currently facing the following challenges: How to stay abreast of this avalanche of data? How to incorporate the data into my day-to-day practice? What testing should I order to correctly classify myelodysplastic and myeloproliferative neoplasms? How should my diagnosis be worded in the face of two new classifications of hematologic neoplasms (5th edition WHO and 2022 International Consensus Classifications). This course, led by four experienced academic hematopathologists practicing at four large cancer centers, will answer all of these questions (and more) by reviewing cases of myeloid neoplasms with myelodysplastic and myeloproliferative features. Join us on the exciting journey from the past to the present and into the future!
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Specialties served/covered
- Anatomic & Clinical Pathology
- Breast Imaging
- Cytopathology
- Dermatopathology
- Endocrinology, Diabetes & Metabolism
- General Surgery
- Head & Neck Surgery
- Hematology
- Hematopathology
- Musculoskeletal Oncology
- Nephrology
- Neuropathology
- Obstetrics & Gynecology
- Patient Safety & Quality Improvement
- Pediatric Pathology
- Urology
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Medical Subspecialties
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pathology & Lab
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
- Enduring / On-demand
- Credit · Up to 12 credits
- MOC · Up to 12 points
- Paid · this provider typically $999
-
ReleasedJun 13, 2024
-
Last day to claim creditMay 7, 2027 7 months left
-
Learner’s Digest International (TM) Update on Myeloproliferative Neoplasms, Myelodysplastic Syndromes, and Myelofibrosis
-
National Comprehensive Cancer Network NCCN Guidelines Insights – Myeloproliferative Neoplasms
-
Physicians’ Education Resource Module 9: Emerging Strategies in Myeloproliferative Neoplasms
-
United States & Canadian Academy of Pathology Hematopathology: Current Classifications and Diagnostic Dilemmas
-
United States & Canadian Academy of Pathology Update On Hematopathology Classification: The International Consensus Classification Perspective
-
United States & Canadian Academy of Pathology 2026 Annual Meeting Long Course – Challenges and Controversies in Hematopathology: Classification Dilemmas in Search of Solutions
